25198-98-5

Basic information

• Product Name: 5-ethylpyrimidin-4-ol
• Synonyms: 5-ethylpyrimidin-4-ol;4(1H)-Pyrimidinone, 5-ethyl- (9CI);5-Ethyl-4(1H)-pyrimidinone;4(3H)-PyriMidinone, 5-ethyl-;5-Ethyl-3H-pyrimidin-4-one
• CAS NO: 25198-98-5
• Molecular Formula: C6H8N2O
• Molecular Weight: 124.14052
• Product Categories: PYRIMIDINE
• Mol File: 25198-98-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 83-85 °C
• Boiling Point: 237.1°Cat760mmHg
• Flash Point: 97.2°C
• Appearance: /
• Density: 1.158g/cm³
• Vapor Pressure: 0.03mmHg at 25°C
• Refractive Index: 1.545
• PKA: 9.16±0.40(Predicted)
• CAS DataBase Reference: 5-ethylpyrimidin-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ethylpyrimidin-4-ol(25198-98-5)
• EPA Substance Registry System: 5-ethylpyrimidin-4-ol(25198-98-5)

Safety Data

• Hazardous Substances Data: 25198-98-5(Hazardous Substances Data)

Usage

General Description

5-ethylpyrimidin-4-ol is a chemical compound with the molecular formula C7H9N3O. It is a derivative of pyrimidine and contains an ethyl group attached to the fourth position of the pyrimidine ring. 5-ethylpyrimidin-4-ol is a heterocyclic organic compound with a hydroxyl group attached to the fourth carbon atom of the pyrimidine ring. It is used in organic synthesis and pharmaceutical research. 5-ethylpyrimidin-4-ol has potential applications in the development of pharmaceutical drugs and agrochemicals due to its unique chemical structure and reactivity. Additionally, it may have biological activity that could make it useful as a drug lead compound for the treatment of various diseases. Overall, 5-ethylpyrimidin-4-ol is a versatile chemical compound with potential applications in various fields.

InChI:InChI=1/C6H8N2O/c1-2-5-3-7-4-8-6(5)9/h3-4H,2H2,1H3,(H,7,8,9)

Upstream product

• 34171-37-4 5-ethyl-2-thiouracil 

Downstream Products

• 1256492-23-5 5-ethyl-4-(piperazin-1-yl)pyrimidine 
• 1255517-76-0 PF-4708671 

Relevant articles and documents

Ozonization of thio- and azauracils

-

2-(3-AMINO-2-HYDROXY-PROPOXY)-PYRAZINES

Heterocyclic compounds of the formula STR1 wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R 1 is hydrogen or methyl and R 2 is lower alkyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) β-rezeptor blocking agents, and/or (cardioselective) β-rezeptor-stimulants.